We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Show more
-ย Poster presentations on BMB-101 will focus on 5-HT2C functional selectivity and Phase 1 clinical dataย ย - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ:...
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (โBright Mindsโ or the โCompanyโ) announces that further to its news...
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.39 | -0.987341772152 | 39.5 | 43.4 | 36.0601 | 96881 | 39.52745455 | CS |
4 | 7.1845 | 22.5039545191 | 31.9255 | 49.46 | 31.895 | 156312 | 40.21532358 | CS |
12 | 37.9 | 3132.23140496 | 1.21 | 79.02 | 0.94 | 3248362 | 35.85594752 | CS |
26 | 38.07 | 3660.57692308 | 1.04 | 79.02 | 0.9305 | 1549416 | 34.69327466 | CS |
52 | 37.68 | 2634.96503497 | 1.43 | 79.02 | 0.93 | 799441 | 34.17818678 | CS |
156 | 21.81 | 126.069364162 | 17.3 | 79.02 | 0.93 | 1477408 | 14.49687901 | CS |
260 | -5.64 | -12.6033519553 | 44.75 | 79.02 | 0.93 | 1435442 | 14.64408191 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions